HUTCHMED GAAP EPADS of $2.62, revenue of $548.51M
Source: SeekingAlpha
2026-03-05 06:08:34 ET
More on HUTCHMED
- Seeking Alpha’s Quant Rating on HUTCHMED
- Historical earnings data for HUTCHMED
- Financial information for HUTCHMED
Read the full article on Seeking Alpha
For further details see:
HUTCHMED GAAP EPADS of $2.62, revenue of $548.51M
HUTCHMED (China) Limited
NASDAQ: HCM
HCM Trading
3.29% G/L:
$14.45 Last:
9,616 Volume:
$14.38 Open:
HCM Latest News
March 09, 2026 05:30:00 am
HUTCHMED Announces Update on Licensed Oncology Product TAZVERIK® in China
March 06, 2026 03:30:00 am
Intended Retirement of Independent Non-executive Director and changes of composition of board committees
March 04, 2026 03:30:00 am
HUTCHMED Initiates Global Trial of PI3K/PIKK-EGFR ATTC Candidate HMPL-A580 in Patients with Solid Tumors
HCM Stock Data
$2,607,787,313
104,485,926
2.8%
28
N/A
Pharmaceuticals
Healthcare
HK
Hong Kong
